Skip to main content

Advertisement

Table 1 Clinical and sociodemographic data (N = 242)

From: Adherence evaluation of endocrine treatment in breast cancer: methodological aspects

  Frequency (%)
Age Median (SD) 65.00 y (8.3y)
  Range 40-84y
Marital status Single 18 (8.4%)
  Partnership, marriage 135 (63.1%)
  Divorced, separated 28 (13.1%)
  Widowed 33 (15.4%)
Employment status Full-time 16 (7.5%)
  Part-time 16 (7.5%)
  Unemployed 5 (2.1%)
  Homemaker 31 (14.5%)
  Retired 142 (66.4%)
  Other 4 (1.6%)
Histological classification Invasive 226 (93.4%)
  In situ 15 (6.2%)
  Missing 1 (0.4%)
Grading Grade I 35 (14.5%)
  Grade II 176 (72.7%)
  Grade III 10 (4.1%)
  Unknown 21 (8.7%)
Duration of adjuvant endocrine therapy (months) Median (SD) 26.7 (19.1) mo.
  Range 0.7- 89.5 mo.
Primary surgical treatment Breast-conserving procedure 155 (65.7%)
  Mastectomy 81 (34.3%)
  Reconstruction 43 (18.2%)
Chemotherapy   41 (16.9%)
Radiotherapy   169 (71.3%)